Identify your patients who you know will struggle with Oral mucositis and prescribe Caphosol.
97% of patients receiving radiation for head and neck cancer develop oral mucositis28
70% of patients receiving haematopoietic stem cell transplantation develop oral mucositis5
Up to 40% of patients receiving conventional chemotherapy develop oral mucositis5
When to use Caphosol?
In patients undergoing Radiotherapy for an underlying head and neck cancer
In patients undergoing raidotherapy and conditioning chemotherapy prior to haematopoietic stem cell transplant
In patients who experienced oral mucositis in one cycle of chemotherapy
Primary Prophylaxis
Secondary Prophylaxis
Start Caphosol on day one of cancer treatment and continue throughout the therapy
Start Caphosol on day one of the next cycle of the cancer treatment if oral mucositis occurred in a previous cycle and continue throughout subsequent cycles
Caphosol is very easy to use and is clinically proven to decrease the incidence, duration and severity of oral mucositis. Don't wait for the onset of symptoms to start Caphosol; damage to the lining of the mouth starts from the first day of cancer therapy. Control oral mucositis by starting Caphosol on the first day of cancer treatment.15
Caphosol can easily be integrated into cancer care to help prevent oral mucositis and support treatment outcomes, please follow these simple instructions:
Caphosol is well tolerated6
- No known drug interactions
Caphosol is easy to use
Simply instruct your patients to
- Mix the 2 ampoules together
- Swish with half the solution for 60 seconds
- Spit out
- Swish again with the other half for 60 seconds
- Spit out
Patients report high satisfaction with Caphosol15
- No unpleasant taste
- Flexible dosing from 4 to 10 times a day depending on the patient's need